West Pharmaceutical Services, Inc. (WST) Stock Price

WSTStock

$337.47+37.49%52W

Market Cap$23.75B

P/E50.22x

PEG Ratio2.99

Div yield0.33%

Beta1.13

WST Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)25.60%

Price vs S&P 500 (4W)-4.55%

PEG Ratio2.99

VGM Score48.21

P/E Ratio (Annual)50.22x

Indicated Dividend Yield (Annual)0.33%

P/CF (Annual)32.85x

Book Value / Share (Quarterly)$42.47

P/TBV (Annual)6.25x

Indicated Dividend (Annual)$0.88

Revenue Growth (3Y)2.12%

Cash Flow / Share (Quarterly)$6.21

Payout Ratio (TTM)11.05%

Price vs S&P 500 (YTD)9.83%

Gross Margin (TTM)36.79%

Net Profit Margin (TTM)16.98%

EPS (TTM)$7.82

10-Day Avg Trading Volume0.43M

EPS Excl Extra (TTM)$7.82

Revenue Growth (5Y)7.44%

EPS (Annual)$6.79

Dividend / Share (Annual)$0.85

ROI (Annual)14.59%

Gross Margin (Annual)35.91%

Net Profit Margin (5Y Avg)19.38%

Cash / Share (Quarterly)$6.19

P/E Basic Excl Extra (TTM)43.89x

Revenue Growth QoQ (YoY)13.80%

EPS Growth (5Y)8.26%

P/E Normalized (Annual)50.22x

ROA (Last FY)11.56%

Revenue Growth TTM (YoY)12.38%

EBITD / Share (TTM)$11.89

ROE (5Y Avg)20.93%

Operating Margin (TTM)20.45%

Cash Flow / Share (Annual)$6.51

P/B Ratio8.29x

P/B Ratio (Quarterly)8.48x

Net Income / Employee (Annual)$45,700

EV / Revenue (TTM)7.38x

Net Interest Coverage (TTM)130.12x

ROA (TTM)13.64%

EPS Growth QoQ (YoY)18.81%

EV / EBITDA (TTM)28.58x

EPS Incl Extra (Annual)$6.79

Current Ratio (Annual)3.02x

Quick Ratio (Quarterly)2.12x

3-Month Avg Trading Volume0.78M

52-Week Price Return37.49%

EV / Free Cash Flow (Annual)52.39x

P/E Incl Extra (TTM)43.89x

Revenue / Employee (TTM)$308,000

Tangible BV / Share (Quarterly)$42.38

P/S Ratio (Annual)8.06x

Asset Turnover (Annual)0.72x

52-Week High$386.00

Operating Margin (5Y Avg)22.38%

EPS Excl Extra (Annual)$6.79

CapEx CAGR (5Y)10.39%

Tangible BV CAGR (5Y)11.68%

26-Week Price Return37.53%

Quick Ratio (Annual)2.34x

13-Week Price Return4.87%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)2.82x

Enterprise Value$24.56B

Revenue / Share Growth (5Y)8.34%

Asset Turnover (TTM)0.80x

Book Value / Share Growth (5Y)11.97%

Revenue / Employee (Annual)$284,600

Inventory Turnover (Annual)4.80x

Pretax Margin (Annual)19.55%

Cash / Share (Annual)$10.99

3-Month Return Std Dev26.15%

Gross Margin (5Y Avg)37.93%

Net Income / Employee (TTM)$52,300

EBITDA CAGR (5Y)2.72%

EBITDA Interim CAGR (5Y)-1.21%

ROE (Last FY)15.54%

Net Interest Coverage (Annual)128.54x

EPS Basic Excl Extra (Annual)$6.79

P/FCF (TTM)56.75x

Receivables Turnover (TTM)4.97x

EV / Free Cash Flow (TTM)56.22x

Total Debt / Equity (Quarterly)0.07x

EPS Incl Extra (TTM)$7.82

Receivables Turnover (Annual)5.29x

ROI (TTM)17.33%

Dividend Growth Rate (5Y)5.48%

P/S Ratio (TTM)7.45x

Pretax Margin (5Y Avg)22.69%

Revenue / Share (Annual)$42.28

Tangible BV / Share (Annual)$44.00

Forward P/E36.01x

Free OCF CAGR (5Y)9.48%

Price vs S&P 500 (52W)18.93%

P/E Ratio (TTM)43.89x

EPS Growth TTM (YoY)17.22%

Year-to-Date Return22.65%

5-Day Price Return-4.49%

EPS Normalized (Annual)$6.79

ROA (5Y Avg)15.35%

Net Profit Margin (Annual)16.06%

Month-to-Date Return-1.02%

Cash Flow / Share (TTM)$8.90

EBITD / Share (Annual)$8.05

EPS Growth (3Y)-4.22%

Operating Margin (Annual)19.03%

LT Debt / Equity (Annual)0.06x

P/CF (TTM)37.44x

ROI (5Y Avg)19.34%

P/E Excl Extra (TTM)43.89x

LT Debt / Equity (Quarterly)0.07x

EPS Basic Excl Extra (TTM)$7.82

P/TBV (Quarterly)8.50x

Payout Ratio (Annual)12.40%

P/B Ratio (Annual)6.23x

Dividend / Share (TTM)$0.88

Inventory Turnover (TTM)4.84x

Pretax Margin (TTM)20.85%

Book Value / Share (Annual)$44.11

Price vs S&P 500 (13W)2.91%

Net Margin Growth (5Y)-0.09%

Dividend Yield (TTM)0.25%

Beta1.13x

P/FCF (Annual)52.87x

Revenue / Share (TTM)$46.66

ROE (TTM)18.51%

52-Week Low$223.83

vGradeD

gGradeC

mGradeB

vgmGradeC

WST Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 23, 2026	$2.08	$2.37	+13.86%(+$0.29)
Q1 2026	Apr 23, 2026	$1.68	$2.13	+27.07%(+$0.45)
Q4 2025	Feb 12, 2026	$1.83	$2.04	+11.54%(+$0.21)
Q3 2025	Oct 23, 2025	$1.71	$1.96	+14.55%(+$0.25)
Q2 2025	Jul 24, 2025	$1.54	$1.84	+19.71%(+$0.30)

WST Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.09

4.14

4.27

4.22

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.55

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services supplies critical packaging and delivery systems to the pharmaceutical, biotechnology, and generic drug industries. Its products include elastomer-based packaging components, nonglass containment solutions, and auto-injectors for biologics, GLP-1 agonists, and small-molecule drugs. The company derives approximately 80% of revenue from proprietary products and 20% from contract manufacturing, with 55% of revenue from international markets.